Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/100 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME16048146
PMID: | 16048146
LR: | 20051117
CED: | 20050728
DCO: | 20051014
Autoren: | Goggs R; Vaughan-Thomas A; Clegg PD; Carter SD; Innes JF; Mobasheri A; Shakibaei M; Schwab W; Bondy CA
Titel: | Nutraceutical therapies for degenerative joint diseases: a critical review.
Quelle: | Critical reviews in food science and nutrition; VOL: 45 (3); p. 145-64 /2005/
PM: | Print
SU: | IM
Sprache: | English
CY: | United States
JID: | 8914818
ISSN: | 1040-8398
CO: | CRFND6
Institution: | Connective Tissue Research Group, Faculty of Veterinary Science, University of Liverpool, Liverpool, United Kingdom.
DT: | Journal Article; Review
RN: | 199
Schlagwörter
CT: | AMINO ACIDS/administration & dosage; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL/therapeutic use; BIVALVIA; CAMELLIA SINENSIS/chemistry; CARTILAGE/chemistry; CARTILAGE/physiology; CHONDROITIN SULFATES/administration & dosage; FATTY ACIDS, ESSENTIAL/administration & dosage; FLAVONOIDS/administration & dosage; GLUCOSAMINE/administration & dosage; GLUCOSE/administration & dosage; HUMANS; NUTRITIONAL STATUS; OBESITY/complications; OSTEOARTHRITIS/*diet therapy; OSTEOARTHRITIS/*drug therapy; OSTEOARTHRITIS/etiology; OSTEOCHONDRITIS DISSECANS/*diet therapy; OSTEOCHONDRITIS DISSECANS/*drug therapy; OSTEOCHONDRITIS DISSECANS/etiology; PHENOLS/administration & dosage; TRACE ELEMENTS/administration & dosage; VITAMINS/administration & dosage
CTG: | AMINOSÄUREN/Verabreichung & Dosierung; TIER; ANTIPHLOGISTIKA, NICHTSTEROIDALE/therapeutische Anwendung; BIVALVIA; CAMELLIA SINENSIS/Chemie; KNORPEL/Chemie; KNORPEL/Physiologie; CHONDROITINSULFATE/Verabreichung & Dosierung; FETTSÄUREN, ESSENTIELLE/Verabreichung & Dosierung; FLAVONOIDE/Verabreichung & Dosierung; GLUCOSAMIN/Verabreichung & Dosierung; GLUCOSE/Verabreichung & Dosierung; MENSCH; ERNÄHRUNGSZUSTAND; ADIPOSITAS/Komplikationen; OSTEOARTHROSE/*Diättherapie; OSTEOARTHROSE/*Arzneimitteltherapie; OSTEOARTHROSE/Ätiologie; OSTEOCHONDRITIS DISSECANS/*Diättherapie; OSTEOCHONDRITIS DISSECANS/*Arzneimitteltherapie; OSTEOCHONDRITIS DISSECANS/Ätiologie; PHENOLE/Verabreichung & Dosierung; SPURENELEMENTE/Verabreichung & Dosierung; VITAMINE/Verabreichung & Dosierung
TE: | Amino Acids; Anti-Inflammatory Agents, Non-Steroidal; Fatty Acids, Essential; Flavonoids; Phenols; Trace Elements; Vitamins; polyphenols; Glucosamine/3416-24-8; Glucose/50-99-7; Chondroitin Sulfates/9007-28-7
CR: | 3416-24-8; 50-99-7; 9007-28-7
AB: | There is growing recognition of the importance of nutritional factors in the maintenance of bone and joint health, and that nutritional imbalance combined with endocrine abnormalities may be involved in the pathogenesis of osteoarthritis (OA) and osteochondritis dissecans (OCD). Despite this, dietary programs have played a secondary role in the management of these connective tissue disorders. Articular cartilage is critically dependent upon the regular provision of nutrients (glucose and amino acids), vitamins (particularly vitamin C), and essential trace elements (zinc, magnesium, and copper). Therefore, dietary supplementation programs and nutraceuticals used in conjunction with non-steroidal, anti-inflammatory drugs (NSAIDs) may offer significant benefits to patients with joint disorders, such as OA and OCD. This article examines the available clinical evidence for the efficacy of nutraceuticals, antioxidant vitamin C, polyphenols, essential fatty acids, and mineral cofactors in the treatment of OA and related joint disorders in humans and veterinary species. This article also attempts to clarify the current state of knowledge. It also highlights the need for additional targeted research to elucidate the changes in nutritional status and potential alterations to the expression of plasma membrane transport systems in synovial structures in pathophysiological states, so that current therapy and future treatments may be better focused.

» Volltext »
» Fenster schließen »